Endoluminal occlusion-irrigation catheter with aspiration capabilities and methods of use

Information

  • Patent Grant
  • 7731683
  • Patent Number
    7,731,683
  • Date Filed
    Tuesday, September 6, 2005
    19 years ago
  • Date Issued
    Tuesday, June 8, 2010
    14 years ago
Abstract
A catheter system comprising a guidewire, an endovascular catheter, and an aspiration catheter. The guidewire has an expandable occluder mounted on a distal end. The guidewire and the endovascular catheter are insertable into a lumen of the aspiration catheter. The aspiration catheter also includes infusion and aspiration lumen(s) and port(s). Methods of using the catheter system for treating a vascular lesion and removing embolic material during the procedure are also disclosed.
Description
FIELD OF THE INVENTION

The present invention generally relates to medical devices for protecting a patient from distal embolization during interventional procedures, such as angioplasty or stent placement for treatment of vascular stenosis. More particularly, the devices comprise a catheter having irrigation and aspiration capabilities, and a guidewire carrying a distal expandable occluder. An endovascular instrument, such as an angioplasty catheter, is insertable into a lumen of the aspiration catheter.


BACKGROUND OF THE INVENTION

Treatments of vascular stenosis or lesions during endovascular procedures, such as atherectomy, balloon angioplasty with or without stent placement, or ablation therapy, are associated with increased risk of distal embolization. Tissue debris, calcium, atheromatous plaque, and/or thrombi generated during the procedure often become lodged downstream in a small vessel of vital organs, causing tissue ischemia or infarction. For example, transient ischemic attack (TIA) and cerebral infarction (stroke) are common complications of performing endovascular procedures on the ascending aorta and the carotid artery.


To reduce the risk of distal embolism, several devices are employed for use in endovascular procedures. For example, blood filters can be deployed distal to a vascular lesion to capture emboli. However, disadvantages associated with the blood filters are that (1) dislodgment of embolic material can occur during insertion and retrieval of the filter device, and (2) blood filters cannot easily be used in small vessels, (e.g., a saphenous vein graft measuring 3 or 4 mm).


Another catheter system described in U.S. Pat. No. 5,833,650 includes occlusion members for providing proximal and distal occlusion to a vascular lesion. Each occlusion member communicates with an inflation lumen. The catheter includes irrigation and aspiration lumens for removing embolic debris generated during the procedure. The catheter also includes a device introducing lumen, which further increases the overall size and diameter of the catheter, making the catheter impracticable for use in smaller vessels.


Theron developed a device having an insertion catheter, a dilation catheter, and an occlusion catheter assembled in a coaxial arrangement, U.S. Pat. No. 5,423,742. The catheter device is inserted across a vascular lesion which is dilated by the dilation catheter. Emboli generated during the dilation is removed by suction through the insertion catheter, while the occlusion catheter provides vascular occlusion distal to the vascular lesion. The major disadvantage associated with the device is that some of the embolic material will not be removed by irrigation and suction, thereby leaving the patient at risk for embolic complication.


Thus, there is a need for devices and methods which effectively remove embolic material generated during endovascular procedures, and that can be used in vessels having various diameters.


SUMMARY OF THE INVENTION

The present invention provides an endoluminal catheter system adapted for insertion into arteries of various sizes, including the femoral artery, the iliac artery, the popliteal artery, the renal artery, the inferior mesenteric artery, the superior mesenteric artery, the celiac artery, the coronary artery, the common carotid artery, the internal carotid artery, the external carotid artery, the subclavian artery, the axillary artery, and the brachial artery. The catheter system is also adapted for insertion into a patient's venous vasculature, including the femoral vein, the iliac vein, the superficial femoral vein, the deep femoral vein, the renal vein, the coronary artery, the internal jugular vein, the external jugular vein, the subclavian vein, the saphenous vein, the azygous vein, the superior vena cava, and the inferior vena cava. The catheter system can accommodate a variety of endovascular instruments, including a blood filter, an angioplasty catheter, a valveoplasty catheter, an electrode catheter, internal vessel segregating or isolating dams, an endoscopic camera, a pressure monitor, a stent, a graft, a shunt, a perfusion catheter, and endoscopic devices.


In a first embodiment, the catheter system includes a guidewire, an endovascular catheter, e.g., angioplasty catheter, and an aspiration catheter. The guidewire has a proximal end, and an expandable occluder mounted on a distal end. The aspiration catheter has first and second lumens. The first lumen communicates between a proximal end and a distal end, and is adapted to receive the guidewire and the endovascular catheter. The second lumen communicates with at least one distal fluid infusion port. In certain embodiments, the catheter includes an aspiration lumen communicating with one or a plurality of distal aspiration ports.


In another embodiment, 2, 3, 4, 5, 6, or any other number of infusion ports are disposed radially about the distal end of the aspiration catheter. The infusion ports are shaped to direct fluid in a circular path radially and distally beyond the distal end of the aspiration catheter. In certain embodiments, the infusion ports are directed radially outward and angled relative to the radius of the catheter.


In another embodiment, the expandable occluder is mounted on a distal end of a support wire, which includes an infusion lumen and port(s). The support wire is insertable through the lumen of the endovascular catheter which includes distal aspiration port(s) and lumen.


In a first method of treating an endovascular lesion using the catheter system described above, the guidewire, which has the expandable occluder placed in a collapsed state, is inserted in the lumen of the aspiration catheter. The aspiration catheter carrying the guidewire is then inserted into a vessel, and the guidewire is advanced to position the occluder distal to a region of interest. An endovascular device, e.g., an angioplasty catheter, is inserted over the proximal end of the guidewire, and advanced to position a dilatation member within the region of interest. The aspiration catheter is advanced over the guidewire and positioned proximal the dilatation member. The occluder on the guidewire is expanded to occlude the vascular lumen distal to the lesion. The dilatation member is expanded to treat the vascular lesion and collapsed after luminal patency is achieved. Fluid, such as saline or Ringer's lactate solution, is infused through the infusion lumen and ports to irrigate the treated lumen. Fluid, blood, and embolic debris are removed through the aspiration lumen under suction. The occluder on the guidewire remains expanded during irrigation and aspiration. In certain embodiments, infusion and aspiration of fluid can create a venturi effect in the vascular lumen between the expanded occluder and the aspiration catheter to facilitate removal of loose emboli and embolic material partially attached to the vascular wall. The surgeon can tell that removal of embolic material is complete after the aspirated fluid turns from red to clear and is free of any debris. In this way, the catheter system is capable of complete removal of emboli.


In another method, fluid is infused through the lumen of a support wire to irrigate the region of interest. Embolic debris, blood, and fluid are removed through the distal aspiration ports and lumen of the endovascular catheter. Radiopaque contrast agent is infused through the infusion lumen to assess luminal patency under fluoroscopy. After treatment of the vascular lesion, the occluder is collapsed, and the catheter system is removed from the vessel.


It will be understood that there are several advantages in using the catheter systems and methods disclosed herein for treating a vascular lesion. For example, the devices (1) can be inserted in arteries or veins of various diameter, (2) provide near-total capture of embolic material, thereby dramatically reducing the risk of distal embolization, (3) accommodate a variety of endovascular instruments, and (4) provide treatment of vascular lesions and emboli protection utilizing one catheter system, thereby obviating the need for device exchange.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 depicts an embodiment of the catheter system for treating a vascular lesion according to the present invention.



FIG. 2 depicts a guidewire inserted in a vessel.



FIG. 3 depicts an aspiration catheter inserted over the guidewire of FIG. 2.



FIG. 4A depicts the catheter system of FIG. 1 inserted in a vessel for treatment of atheromatous lesions.



FIG. 4B depicts a cross-sectional view of the catheter system of FIG. 4A through sectional line B-B.



FIG. 4C depicts a cross-sectional view of the catheter system of FIG. 4A through sectional line C-C.



FIG. 5A depicts irrigation and aspiration of vascular debris after angioplasty using the catheter system of FIG. 1.



FIG. 5B depicts the catheter system of FIG. 5A having the angioplasty catheter withdrawn within the lumen of the aspiration catheter.



FIG. 6A depicts another embodiment of the aspiration catheter having a plurality of infusion ports shaped to direct fluid flow.



FIG. 6B depicts a distal view of the catheter system of FIG. 6A from cross-sectional line B-B.



FIG. 7 depicts cross-sectional views of another embodiment of the aspiration catheter irrigating vascular lumens of varying diameters.



FIG. 8 depicts another embodiment of the catheter system having a stent deployment catheter.



FIG. 9A depicts the catheter system of FIG. 8 deploying a stent into a vessel.



FIG. 9B depicts the stent deployment catheter of FIG. 9A withdrawn into the lumen of the aspiration catheter.



FIG. 10 depicts the catheter system of FIG. 8 inserted into the left common carotid artery for treatment of carotid stenosis.



FIG. 11 depicts another embodiment of the catheter system having a support wire inserted through an endovascular catheter.



FIG. 12A depicts an embodiment of the support wire having an expandable occluder mounted on a distal end.



FIG. 12B depicts the occluder of the support wire of FIG. 12A in a collapsed state.



FIG. 12C depicts a cross-sectional view of the support wire of FIG. 12A through section line B-B.



FIG. 12D depicts a cross-sectional view of the support wire of FIG. 12B through section line D-D.





DETAILED DESCRIPTION

Referring now to the drawings, an embodiment of the catheter system for treating a vascular lesion is depicted in FIG. 1. The system generally comprises guidewire 10, angioplasty catheter 20, and aspiration catheter 30. Guidewire 10 has proximal end 11 and distal end 12. An expandable occluder, shown as balloon 15 which communicates with inflation lumen 16 and proximal port 17, is mounted on distal end 12. Balloon 15 can be expanded by infusing air, gas, or saline through proximal port 17. Guidewire 10 is inserted through lumen 22 of angioplasty catheter 20. Lumen 22 communicates with proximal end 21 and distal end 23. Dilatation member, shown as expandable balloon 25 which communicates with inflation lumen 26 and inflation port 27, is mounted on distal end 23 of the catheter. Dilatation balloon 25 can be expanded by infusing air, gas, or saline through proximal port 27. Angioplasty catheter 20 is inserted through lumen 33 of aspiration catheter 30. Lumen 33 communicates with proximal end 31 and distal end 32. Hemostatic valve 40 is included in proximal end 31 to prevent back flow of blood during catheter insertion. The aspiration catheter includes infusion ports 35 at distal end 32. Lumen 33 and infusion ports 35 may be located proximate each other at distal end 32. Each infusion port communicates with infusion lumen 36 and proximal infusion port 37. In certain embodiments, the infusion ports communicate with a single infusion lumen and port. Lumen 33, which communicates with suction lumen 39, is adapted for aspiration of fluid, air or debris. Lumen 39 extends from proximal end 31 and is adapted for attachment to a vacuum at a proximal end.


In use, guidewire 10 with balloon occluder 15 in a collapsed state is inserted through an incision on a peripheral artery and advanced to vascular lesion 101 as depicted in FIG. 2. Aspiration catheter 30 is then inserted over guidewire 10 into vessel 100 proximal to lesion 101 as depicted in FIG. 3. Alternatively, guidewire 10 is inserted into lumen 33 of aspiration catheter 30 prior to insertion into the vessel.


Angioplasty catheter 20 is inserted into lumen 33 of aspiration catheter 30 and advanced to position dilatation balloon 25 over lesion 101 as depicted in FIG. 4A. Distal end 32 of the aspiration catheter is positioned proximal of balloon 25. Balloon 15 of the guidewire is then inflated to occlude the lumen of vessel 100, thereby protecting emboli from traveling downstream to other organs when dilatation balloon 25 is expanded against lesion 101. In other methods, balloon 15 is inflated before the positioning of angioplasty catheter 20 in the region of interest, and in other methods before positioning the aspiration catheter 30 proximal to the region of interest. A cross-sectional view of the catheter system proximal to lesion 101 is depicted in FIG. 4B. A cross-sectional view of the catheter system acting to cause dilation of lesion 101 is depicted in FIG. 4C.


During angioplasty, inflation of the dilatation balloon often causes fissure of an atheromatous lesion, which commonly includes calcium, cholesterol plaque, and thrombi, thereby liberating embolic debris. After the dilatation balloon is expanded against the atheromatous lesion to re-establish lumenal patency, the dilatation balloon is deflated. Radiopaque contrast agent can be infused through infusion ports 35 to assess the diameter of the vascular lumen under fluoroscopy. Fluid, such as saline or Ringer's lactate solution, is infused through infusion lumens 36 and ports 35 to irrigate the vascular region including the distal end of the angioplasty catheter as shown in FIG. 5A. Lumen 33 is attached to suction, and fluid, blood, and debris are aspirated into lumen 33 and removed. The distal end of the angioplasty catheter is maintained proximal to balloon occluder 15 and distal to aspiration catheter during irrigation and aspiration of embolic debris.


Alternatively, the distal end of angioplasty catheter 20 is withdrawn proximal, into lumen 33 of aspiration catheter 30, in certain cases, prior to irrigation and aspiration as shown in FIG. 5B. The color of the aspirate is monitored at the proximal end of aspiration catheter. Removal of embolic debris is complete when the color of the aspirate turns from red to clear and the aspirate is free of any debris. After angioplasty, balloon 15 on the guidewire is deflated to re-establish vascular flow, and the catheter system is removed from the vessel.



FIG. 6A depicts another embodiment of aspiration catheter 30 having a plurality of infusion ports 35 which comprise angled slots. Ports 35 are shaped to direct fluid radially and distally beyond distal end 32. When suction is attached to the lumen 33 of aspiration catheter 30, a venturi effect is created, causing the irrigated fluid to circulate circumferentially about catheter 30, similar to a whirlwind as depicted in FIG. 6B. This irrigation/aspiration system increases the contact of fluid with the vascular wall, thereby increasing the effectiveness of removing embolic debris and loosely attached plaque or thrombi.



FIG. 7 depicts cross-sectional views of another embodiment of aspiration catheter 30 having angled infusion ports 35 for directing fluid flow. Catheter 30 is inserted in vessels of varying diameter. The catheter is also effective in generating a whirlpool-like irrigation pattern when the catheter is positioned adjacent the vascular wall. The catheter can be repositioned within around the vascular lumen to remove embolic debris.



FIG. 8 depicts another embodiment of the catheter system having angioplasty catheter 20 replaced with stent deployment catheter 50 inserted through lumen 33 of aspiration catheter 30. Stent 55 is mounted on distal end 53 of catheter 50 and is operable through actuating mechanism 57 at the proximal end. In certain embodiments, stent 55 is made from shape-memory material, e.g., nitinol. The stent is therefore self-expanding at body temperature and is simply released to actuate. Lumen 54 of catheter 50 is adapted to receive guidewire 10, which has an arcuate distal end 12 to assist guidance through vessels. The aspiration catheter includes infusion ports 35 at distal end 32. Each infusion port communicates with lumen 36 and proximal infusion port 37. Aspiration catheter 30 also includes aspiration lumens 38, which communicate with suction lumens 39 adapted for attachment to a vacuum at a proximal end. In certain embodiments, aspiration lumens 38 communicate with a single suction lumen 39.


In use, aspiration catheter 30 and guidewire 10 with balloon occluder 15 in a collapsed state are inserted into a vessel. The guidewire is advanced distal to vascular lesion 101 as depicted in FIG. 9A. Distal end 32 of the aspiration catheter is positioned proximal lesion 101. Stent deployment catheter 50 with stent 55 in a collapsed state is inserted into lumen 33 of aspiration catheter 30 and advanced within lesion 101. Balloon 15 of the guidewire is inflated, either before or after introduction of the aspiration catheter and stent deployment catheter, to occlude the lumen of vessel 100, thereby protecting emboli from traveling downstream to other organs when stent 55 is expanded against lesion 101 by operating the actuating mechanism. After lumenal patency is re-established by deployment of the stent, fluid is infused through lumen infusion lumens 36 and ports 35 to irrigate the vascular lumen within stent 55 while the distal end of catheter 50 remains within the stent as shown in FIG. 9A. Lumens 38 are attached to suction, and fluid, blood, and debris are aspirated into lumen 38 and removed.


Alternatively, the distal end of catheter 50 is withdrawn into lumen 33 of aspiration catheter 30 prior to irrigation and aspiration as shown in FIG. 9B. Removal of embolic debris is complete when the color of the aspirate turns from red to clear and the aspirate is free of any debris. After stent placement, balloon 15 on the guidewire is deflated to re-establish vascular flow, and the catheter system is removed from the vessel.



FIG. 10 depicts the catheter system of FIG. 8 inserted into left common carotid artery 150 for treatment of carotid stenosis. The catheter system is inserted through an incision in left femoral artery 160 and advanced into the left common carotid artery via descending aorta 155. Stent 55 is deployed within lesion 101 while balloon occluder 15 of guidewire 10 is expanded to prevent distal embolization to the brain. Embolic material generated during carotid stenting is removed by irrigation and aspiration through catheter 30, thereby reducing the risk of cerebral ischemia and/or infarct.



FIG. 11 depicts another embodiment of the catheter system for treatment of a vascular lesion. Expandable balloon occluder 15 is mounted on distal end 71 of support wire 70, which is insertable through the lumen of angioplasty catheter 20.


In use, prior to inserting support wire 70 into a vessel, balloon occluder 15 is placed in a collapsed state by closing inflation valve 19 as depicted in FIGS. 12B and 12D. An endoluminal device, such as angioplasty catheter 20 having angioplasty balloon 25 mounted on a distal end, is inserted over support wire 70, and within aspiration catheter 30. After distal end 71 of the support wire is positioned downstream the region of interest, balloon occluder 15 is expanded by opening inflation valve 19 and infusing fluid or air through inflation lumen 16 as depicted in FIGS. 12A and 12C. Fluid, such as saline or Ringer's lactate, is infused through lumen 77 and port 75 to irrigate within the region of interest. Embolic debris, blood, fluid, and air are aspirated either or both of through aspiration port 76 of angioplasty catheter 20 and lumen 33 of aspiration catheter 30.


The length of the aspiration catheter will generally be between approximately 40 and 120 centimeters, preferably between approximately 60 and 80 centimeters. The length of the guidewire will generally be between approximately 50 and 130 centimeters, preferably between approximately 70 to 100 centimeters. The inner diameter of the aspiration catheter will generally be between approximately 0.5 and 2.0 centimeters, preferably approximately 0.8 and 1.5 centimeters for use in the aorta. The inner diameter of the guidewire will generally be between approximately 0.005 and 0.02 inches, preferably approximately 0.008 and 0.014 inches. The diameter of the expanded occluder on the guidewire will generally be between 2 and 6 centimeters, preferably approximately 3 and 5 centimeters for use in the aorta. For use in the carotid arteries, the inner diameter of the aspiration catheter will generally be between approximately 0.2 and 1.5 centimeters, preferably approximately 0.5 and 1.0 centimeters, and the diameter of the expanded occluder on the guidewire will generally be between 1 and 3 centimeters, preferably approximately 1.5 and 2.5 centimeters. The foregoing ranges are set forth solely for the purpose of illustrating typical device dimensions. The actual dimensions of a device constructed according to the principles of the present invention may obviously vary outside of the listed ranges without departing from those basic principles.


Although the foregoing invention has, for purposes of clarity of understanding, been described in some detail by way of illustration and example, it will be obvious that certain changes and modifications may be practiced which will still fall within the scope of the appended claim. It will also be understood that each feature of each embodiment discussed herein, and of each reference cited herein, can be used in combination with the features of any other embodiment.

Claims
  • 1. An endoluminal aspiration catheter assembly, comprising: a guidewire having a proximal end, a distal end, and an expandable occlusive member disposed on the distal end;an angioplasty catheter having a proximal end, a distal end, a lumen adapted to receive the guidewire, and an expandable dilatation member disposed on the distal end of the angioplasty catheter;an aspiration catheter having a proximal end, a distal end, first lumen in fluid communication with a source of suction, and an infusion lumen in fluid communication with a source of infusion fluid and a plurality of fluid infusion ports disposed radially about the distal end of the aspiration catheter, the plurality of fluid infusion ports in fluid communication with the infusion lumen, wherein the first lumen has a proximal end and a distal end and the distal end of the first lumen is proximate the plurality of fluid infusion ports; andwherein the infusion ports are adapted to create a venturi effect wherein irrigation fluid ejected from the infusion ports is circulated circumferentially about the aspiration catheter.
  • 2. The catheter assembly of claim 1, wherein the expandable occlusive member is a balloon.
  • 3. The catheter assembly of claim 2, wherein the guidewire further includes an inflation lumen in fluid communication with the balloon.
  • 4. The catheter assembly of claim 1, wherein the infusion ports are angled slots formed within the aspiration catheter.
  • 5. The catheter assembly of claim 1, wherein the infusion ports are directed radially outward and angled relative to the radius of the aspiration catheter.
  • 6. The catheter assembly of claim 1, wherein said source of infusion fluid includes a radiopaque contrast agent.
  • 7. The catheter assembly of claim 1, wherein the first lumen of the aspiration catheter is adapted to receive the angioplasty catheter therein.
  • 8. The catheter assembly of claim 1, wherein the angioplasty catheter is a stent deployment catheter insertable through an aspiration lumen of the aspiration catheter.
  • 9. An endoluminal aspiration catheter assembly, comprising: a guidewire having a proximal end, a distal end, and an expandable occlusive member disposed on the distal end;an angioplasty catheter having a proximal end, a distal end, a lumen adapted to receive the guidewire, and an expandable dilatation member disposed on the distal end of the angioplasty catheter;an aspiration catheter having a proximal end, a distal end, first lumen in fluid communication with a source of suction, and an infusion lumen in fluid communication with a source of infusion fluid and a plurality of fluid infusion ports disposed radially about the distal end of the aspiration catheter, the plurality of fluid infusion ports in fluid communication with the infusion lumen, wherein the first lumen has a proximal end and a distal end and the distal end of the first lumen is proximate the plurality of fluid infusion ports; andwherein one or more of said infusion ports includes an angled slot configured to direct fluid in a circular path radially and distally beyond the distal end of the aspiration catheter.
Parent Case Info

This is a continuation application of U.S. application Ser. No. 09/470,026 filed Dec. 22, 1999, now abandoned.

US Referenced Citations (130)
Number Name Date Kind
3472230 Fogarty Oct 1969 A
3952747 Kimmell, Jr. Apr 1976 A
3996938 Clark, III Dec 1976 A
4425908 Simon Jan 1984 A
4643184 Mobin-Uddin Feb 1987 A
4662885 DiPisa, Jr. May 1987 A
4706671 Weinrib Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4790813 Kensey Dec 1988 A
4794928 Kletschka Jan 1989 A
4857045 Rydell Aug 1989 A
4873978 Ginsburg Oct 1989 A
4886061 Fischell et al. Dec 1989 A
4950238 Sullivan Aug 1990 A
4969891 Gewertz Nov 1990 A
RE33569 Gifford, III et al. Apr 1991 E
5011488 Ginsburg Apr 1991 A
5071407 Termin et al. Dec 1991 A
5116317 Carson et al. May 1992 A
5133733 Rasmussen et al. Jul 1992 A
5160342 Reger et al. Nov 1992 A
5192286 Phan et al. Mar 1993 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5370657 Irie Dec 1994 A
5415630 Gory et al. May 1995 A
5419774 Willard et al. May 1995 A
5462529 Simpson et al. Oct 1995 A
5536242 Willard et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5769816 Barbut et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5807398 Shaknovich Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5833650 Imran Nov 1998 A
5843022 Willard et al. Dec 1998 A
5848964 Samuels Dec 1998 A
5873889 Chin Feb 1999 A
5911734 Tsugita et al. Jun 1999 A
5928181 Coleman et al. Jul 1999 A
5938645 Gordon Aug 1999 A
6013085 Howard Jan 2000 A
6022336 Zadno-Azizi et al. Feb 2000 A
6066149 Samson et al. May 2000 A
6066158 Engelson et al. May 2000 A
6080170 Nash et al. Jun 2000 A
6126635 Simpson et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6146370 Barbut Nov 2000 A
6152946 Broome et al. Nov 2000 A
6156048 Wulfman et al. Dec 2000 A
6165196 Stack et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6190355 Hastings Feb 2001 B1
6190357 Ferrari et al. Feb 2001 B1
6193685 Goodin Feb 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206868 Parodi Mar 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6254571 Hart Jul 2001 B1
6277139 Levinson et al. Aug 2001 B1
6398773 Bagaoisan et al. Jun 2002 B1
6423032 Parodi Jul 2002 B2
6443922 Roberts et al. Sep 2002 B1
6443924 Rowland et al. Sep 2002 B1
6451043 McInnes et al. Sep 2002 B1
6454741 Muni et al. Sep 2002 B1
6485500 Kokish et al. Nov 2002 B1
6503224 Forman et al. Jan 2003 B1
6544276 Azizi Apr 2003 B1
6558401 Zadno-Azizi May 2003 B1
6589214 McGuckin, Jr. et al. Jul 2003 B2
6595953 Coppi et al. Jul 2003 B1
6605102 Mazzocchi et al. Aug 2003 B1
6652546 Nash et al. Nov 2003 B1
6669662 Webler Dec 2003 B1
6682505 Bates et al. Jan 2004 B2
6682543 Barbut et al. Jan 2004 B2
6749619 Ouriel et al. Jun 2004 B2
6755813 Ouriel et al. Jun 2004 B2
6805692 Muni et al. Oct 2004 B2
6849068 Bagaoisan et al. Feb 2005 B1
20010039411 Johansson et al. Nov 2001 A1
20010044598 Parodi Nov 2001 A1
20010047147 Slepian et al. Nov 2001 A1
20010047184 Connors Nov 2001 A1
20010049517 Zadno-Azizi et al. Dec 2001 A1
20010056274 Perkins et al. Dec 2001 A1
20020016564 Courtney et al. Feb 2002 A1
20020016565 Zadno-Azizi et al. Feb 2002 A1
20020065507 Zadno-Azizi May 2002 A1
20020091362 Maginot et al. Jul 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020165574 Ressemann et al. Nov 2002 A1
20020169436 Gurm et al. Nov 2002 A1
20020183826 Dorn et al. Dec 2002 A1
20020188276 Evans et al. Dec 2002 A1
20030009146 Muni et al. Jan 2003 A1
20030050600 Ressemann et al. Mar 2003 A1
20030130673 Trerotola Jul 2003 A1
20030163081 Constantz et al. Aug 2003 A1
20040006306 Evans et al. Jan 2004 A1
20040054347 Zadno-Azizi et al. Mar 2004 A1
20040059372 Tsugita Mar 2004 A1
20040064179 Linder et al. Apr 2004 A1
20040098022 Barone May 2004 A1
20040122362 Houser et al. Jun 2004 A1
20040153094 Dunfee et al. Aug 2004 A1
20040220521 Barbut Nov 2004 A1
20050065460 Laird Mar 2005 A1
20050065469 Tai Mar 2005 A1
20050085769 MacMahon et al. Apr 2005 A1
20050124849 Barbut et al. Jun 2005 A1
20050131446 Coughlin et al. Jun 2005 A1
20050131453 Parodi Jun 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050149103 Connors, III Jul 2005 A1
20050154344 Chang et al. Jul 2005 A1
20050159640 Barbut et al. Jul 2005 A1
20050228432 Hogendijk et al. Oct 2005 A1
20050245866 Zadno-Azizi Nov 2005 A1
20050245894 Zadno-Azizi Nov 2005 A1
Foreign Referenced Citations (1)
Number Date Country
9601591 Jan 1996 WO
Related Publications (1)
Number Date Country
20060041304 A1 Feb 2006 US
Continuations (1)
Number Date Country
Parent 09470026 Dec 1999 US
Child 11220227 US